×
About 127,638 results

ALLMedicine™ Lung Cancer Center

Research & Reviews  41,916 results

MiR-144-3p inhibits the proliferation and metastasis of lung cancer A549 cells via targ...
https://doi.org/10.1186/s13019-022-01861-3 10.1038/nrg1379 10.1096/fj.12-213439 10.1038/msb.2011.100 10.1681/ASN.2016101117 10.1038/nrneph.2011.26 10.3892/ijmm.2012.1182 10.1016/j.molcel.2011.08.021 10.1158/0008-5472.CAN-12-1223 10.1016/j.molmed.2014.06.005 10.1159/000369755 10.1016/j.canlet.2011.07.026 10.1016/j.ijrobp.2014.09.021 10.1007/s13105-019-00681-9 10.1371/journal.pone.0048086 10.1158/0008-5472.CAN-05-0137 10.1038/bjc.2012.326 10.1007/s13277-014-2017-7 10.1093/abbs/gmab118 10.3892/ol.2016.4468 10.1158/0008-5472.CAN-04-2650 10.1038/sj.bjc.6603884 10.1371/journal.pone.0058929 10.1002/jcb.24565 10.1016/j.ejphar.2017.05.040 10.1080/15548627.2019.1580105 10.3892/ol.2015.3943 10.3892/ijmm.2014.1963 10.1007/s00535-011-0456-0 10.1007/s12020-014-0326-7 10.1007/s10555-007-9107-6 10.1074/jbc.M006412200 10.1016/j.bbrc.2015.07.108 10.1097/JTO.0000000000000145 10.3892/or.2014.3560 10.1016/j.jss.2009.12.016 10.1093/oxfordjournals.jbchem.a021283 10.1016/S0003-4975(98)01165-5 10.1038/bjc.1996.646 10.1038/nrc779 10.18632/oncotarget.2049 10.1093/carcin/bgs346 10.1158/0008-5472.CAN-10-2738
Journal of Cardiothoracic Surgery; Fang G, Zhang C et. al.

May 16th, 2022 - MicroRNAs have been confirmed as vital regulators in gene expression, which could affect multiple cancer cell biological behaviors. This study aims to elucidate the molecular mechanism of miR-144-3p in lung cancer cellular proliferation and metast...

ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Wi...
https://doi.org/10.1245/s10434-022-11687-x
Annals of Surgical Oncology; Kuo SW, Chen PH et. al.

May 16th, 2022 - ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.|2022|Kuo SW,Chen PH...

Awareness of Tobacco-Related Diseases among Adults in Poland: A 2022 Nationwide Cross-S...
https://doi.org/10.3390/ijerph19095702
International Journal of Environmental Research and Publi... Szymański J, Ostrowska A et. al.

May 15th, 2022 - Warning about the dangers of tobacco use is a key element of tobacco control policy. The COVID-19 pandemic may impact public perception of the health risks of tobacco use. The aim of this study was to assess the level of knowledge of tobacco-relat...

see more →

Guidelines  93 results

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
https://doi.org/10.1200/JCO.21.02528
Journal of Clinical Oncology : Official Journal of the Am... Daly ME, Singh N et. al.

Dec 23rd, 2021 - To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non-small-cell lung cancer (NSCLC). An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary oncology, communit...

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628757
Current Oncology (Toronto, Ont.); Cheema PK, Banerji SO et. al.

Dec 14th, 2021 - In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatm...

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2021.0058
Journal of the National Comprehensive Cancer Network : JN... Ganti AKP, Loo BW et. al.

Dec 14th, 2021 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment...

Updated USPSTF screening guidelines may reduce lung cancer deaths.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619807
The Journal of Family Practice; Marshall RC, Tiglao SM et. al.

Nov 25th, 2021 - By nearly doubling the number of patients eligible for screening, as many as 60,000 US lives may be saved-but concerns may limit acceptance.

Definition and assessment of high risk in patients considered for lobectomy for stage I...
https://doi.org/10.1016/j.jtcvs.2021.07.030
The Journal of Thoracic and Cardiovascular Surgery; Pennathur A, Brunelli A et. al.

Oct 31st, 2021 - Lobectomy is a standard treatment for stage I non-small cell lung cancer, but a significant proportion of patients are considered at high risk for complications, including mortality, after lobectomy and might not be candidates. Identifying who is ...

see more →

Drugs  199 results see all →

Clinicaltrials.gov  2,403 results

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
https://clinicaltrials.gov/ct2/show/NCT02759835

May 13th, 2022 - Background: EGFR tyrosine kinase inhibitors (TKI) have significantly improved the response rate (RR) and survival in patients with tumors harboring EGFR-sensitizing mutations. An invariable consequence of treatment with EGFR-TKIs is the developmen...

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
https://clinicaltrials.gov/ct2/show/NCT03554473

May 13th, 2022 - Background Small cell lung cancer (SCLC) is an aggressive cancer with a poor prognosis. Although highly responsive to chemotherapy initially, SCLC relapses quickly and becomes refractory to treatment within a few months. Extrapulmonary small cell ...

Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT05372081

May 13th, 2022 - Lung cancer is the primary cause of cancer death worldwide regardless of gender or age group. Based on the most recent statistics for our country, every year about 9000 new cases of lung cancer are diagnosed. Lung cancer is the most common type of...

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer With Activating EGFR or HER2 Mutations, Including Exon 20 Insertion Mutations
https://clinicaltrials.gov/ct2/show/NCT05364073

May 13th, 2022 - This is a Phase 1b, open-label, multi-center, dose-escalation and dose-expansion study designed to evaluate the safety, pharmacokinetics (PK), and preliminary antitumor activity of furmonertinib in patients with advanced or metastatic NSCLC with a...

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
https://clinicaltrials.gov/ct2/show/NCT04158141

May 13th, 2022 - PRIMARY OBJECTIVE: I. To detect an improvement in overall survival with the addition of adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) to surgery and chemotherapy compared to surgery and chemotherapy alone. SECONDARY...

see more →

News  6,393 results

Nearly 234,000 Cancer Cases Predicted in Canada This Year
https://www.medscape.com/viewarticle/973931

May 13th, 2022 - About 233,900 new cancer cases and 85,100 cancer deaths are predicted to occur in Canada in 2022, according to new research. The most commonly diagnosed cancer overall will be lung cancer, followed by breast cancer for women and prostate cancer fo...

New Class of Cancer Drugs Down, Not Out, After Roche Trial Setback: Analysts
https://www.medscape.com/viewarticle/973822

May 12th, 2022 - LONDON (Reuters) - The fresh blow to Roche's hopes in a closely watched class of cancer immunotherapies cast a long shadow across the crowded field on Wednesday, but the latest setback is not the end of the road for these oncology treatments, anal...

Quitting Smoking Even After Lung Cancer Diagnosis Worth Doing
https://www.medscape.com/viewarticle/973861

May 12th, 2022 - Patients who quit smoking at or around the time of a lung cancer diagnosis live longer than those who continue to smoke, concludes a new meta-analysis. "Smokers who quit smoking at or around lung cancer diagnosis have a 29% improvement in their ov...

Risk of Dying From New Cancer Higher in Young Cancer Survivors
https://www.medscape.com/viewarticle/973908

May 12th, 2022 - Adolescent and young adult (AYA) cancer survivors face nearly a two-fold higher risk of dying from a new primary cancer compared with peers in the general population, new research shows. "These findings underscore the critical role of providing hi...

Women With Lung Cancer Live Longer Than Men
https://www.medscape.com/viewarticle/973778

May 11th, 2022 - The observation that women with lung cancer seem to live longer than men can be explained by known prognostic factors, a new study suggests. “In this first Australian prospective study of lung cancer survival comparing men and women, we found that...

see more →

Patient Education  51 results see all →